🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
12/03/2015 0,4294 USD
11/12/2014 0,4294 USD
11/09/2014 0,4198 USD
12/06/2014 0,4198 USD
13/03/2014 0,4198 USD
12/12/2013 0,4198 USD
12/09/2013 0,4103 USD
13/06/2013 0,4103 USD
13/03/2013 0,4103 USD
13/12/2012 0,4103 USD
13/09/2012 0,4008 USD
13/06/2012 0,4008 USD
13/03/2012 0,4008 USD
13/12/2011 0,4008 USD
13/09/2011 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/09/2010 34,48 35,03 34,47 34,97 +1,58% 1,63% 11.760.656
09/09/2010 34,34 34,57 34,15 34,43 +0,75% 1,22% 12.119.596
08/09/2010 33,73 34,35 33,72 34,17 +0,99% 1,87% 23.207.750
07/09/2010 34,13 34,13 33,79 33,84 -0,37% 1,01% 26.548.250
03/09/2010 34,09 34,20 33,66 33,96 +0,68% 1,57% 12.049.904
02/09/2010 34,06 34,13 32,94 33,73 -0,76% 3,50% 12.121.482
01/09/2010 33,76 34,12 33,65 33,99 +1,31% 1,38% 13.684.470
31/08/2010 33,07 33,74 32,93 33,55 +1,24% 2,45% 17.379.194
30/08/2010 33,32 33,60 33,13 33,14 -0,77% 1,40% 7.099.466
27/08/2010 33,04 33,50 32,75 33,40 +1,51% 2,28% 10.004.313
26/08/2010 32,98 33,11 32,71 32,90 -0,17% 1,22% 8.903.074
25/08/2010 32,84 33,13 32,46 32,96 +0,29% 2,03% 11.114.878
24/08/2010 33,17 33,21 32,61 32,86 -1,52% 1,81% 11.799.642
23/08/2010 33,11 33,61 32,98 33,37 +1,54% 1,90% 10.455.477
20/08/2010 32,97 33,10 32,68 32,86 -0,78% 1,27% 12.782.875
19/08/2010 33,68 33,72 32,92 33,12 -1,87% 2,38% 12.061.327
18/08/2010 33,86 33,96 33,43 33,75 -0,48% 1,58% 9.571.174
17/08/2010 33,58 33,99 33,34 33,91 +1,63% 1,93% 11.189.496
16/08/2010 33,18 33,40 33,01 33,37 -0,09% 1,18% 7.217.052
13/08/2010 33,21 33,54 33,06 33,40 -0,11% 1,44% 9.172.306
12/08/2010 33,06 33,64 33,02 33,44 +0,43% 1,88% 9.597.479
11/08/2010 33,69 33,87 33,23 33,29 -2,46% 1,93% 13.039.321
10/08/2010 33,59 34,34 33,23 34,13 +1,16% 3,32% 12.434.206
09/08/2010 33,45 33,82 33,45 33,74 +1,09% 1,08% 10.796.496
06/08/2010 33,23 33,40 32,92 33,38 -0,26% 1,44% 12.218.422
05/08/2010 33,40 33,55 33,11 33,46 -0,34% 1,31% 10.545.710
04/08/2010 33,19 33,64 32,97 33,58 +1,06% 2,01% 13.764.013
03/08/2010 33,49 33,64 32,90 33,23 -0,71% 2,19% 15.282.146
02/08/2010 33,26 33,51 32,97 33,46 +1,77% 1,64% 12.688.031
30/07/2010 32,78 33,04 32,27 32,88 -1,71% 2,36% 22.764.656